Related Experiment Videos
High-dose recombinant interleukin-2/verapamil combination in advanced cancer
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC after progression on first-line osimertinib: ORCHARD.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Fetal treatment of sacrococcygeal teratoma: state of the art.
Frontiers in pediatrics·2025
Corrigendum: Gut and spleen anomalies associated with DYRK1A syndrome.
Frontiers in pediatrics·2024
Expression patterns of potential targets for antibody-directed therapy in metastatic castration-resistant prostate cancer patients.
European journal of cancer (Oxford, England : 1990)·2026
Evaluating safety: Number needed to harm analyses of androgen receptor inhibitors in advanced prostate cancer.
European journal of cancer (Oxford, England : 1990)·2026
Integrating patient preferences into clinical trial outcomes for older adults with cancer: A perspective from the EORTC Older Adult Council and Quality of Life Group.
European journal of cancer (Oxford, England : 1990)·2026
Immune remodelling and molecular profiling of progressive brain metastases following cranial radiotherapy.
European journal of cancer (Oxford, England : 1990)·2026
Neurocognitive functioning in long-term survivors of glioblastoma, IDH-wildtype and astrocytoma, IDH-mutant, CNS WHO grade 4: A report from EORTC 1419 (ETERNITY).
European journal of cancer (Oxford, England : 1990)·2026
AI-generated smoking prevention videos on Instagram achieve greater reach when short-term consequences are addressed.
European journal of cancer (Oxford, England : 1990)·2026
Treatment Initiation of Definitive Radiotherapy in Patients With Locally Advanced Head and Neck Cancer.
Cancer control : journal of the Moffitt Cancer Center·2026
Octreotide as Adjunctive Therapy for Catecholamine-Secreting Pheochromocytoma and Paraganglioma.
The Journal of clinical endocrinology and metabolism·2026
Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naïve patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison.
Journal of comparative effectiveness research·2026